2023 Impact Factor: 0.9
2023 CiteScore: 1.8
pISSN: 1735-7020
eISSN: 2008-238x
Editor-in-Chief:
Gholamhossein Edrissian, Pharm. D.
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
The Editorial Board of the journal, reserves the right to accept or reject the article in any stage and any time or delete a part of the text, tables or figures, if necessary.
Important Note: After approving the galley proof by the Corresponding Author, no changes would be accepted at all, especially changing the name of authors or changing the affiliations. The whole responsibility in this case, would be on the authors' side.
2023 Impact Factor: 0.9
2023 CiteScore: 1.8
pISSN: 1735-7020
eISSN: 2008-238x
Editor-in-Chief:
Gholamhossein Edrissian, Pharm. D.
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |